← back to search

Jonathan Sandoe

Leeds Teaching Hospitals NHS Trust · GB
Area of research
Epidemiology · Pharmacology
Research interest
Research interests include Infective Endocarditis Diagnosis and Management, Drug-Induced Adverse Reactions, Antibiotic Use and Resistance, and Pharmacovigilance and Adverse Drug Reactions.
h-index
41
citations
8,505
works
237
NIH funding
primary concept
Medicine
email

Recent publications

Capnocytophaga canimorsus endocarditis following a dog lick - a case report.
2026cited by 0position: contributordoi
What are patients' and healthcare professionals' views on managing penicillin allergy? A qualitative evidence synthesis.
2026cited by 0position: contributordoi
Parental awareness and management of antibiotic side effects and allergies in children and young people: a UK survey.
2026cited by 0position: contributordoi
UK Antimicrobial Registry: Virtual Registry-an innovative surveillance approach for monitoring the real-world use and effectiveness of newly licensed antimicrobials in Scotland.
2026cited by 0position: contributordoi
Widening access to penicillin allergy assessment in the United Kingdom-a proposed implementation plan for the National Health Service (NHS).
2026cited by 0position: contributordoi
Penicillin allergy assessment pathway versus usual clinical care for primary care patients with a penicillin allergy record in the UK (ALABAMA): an open-label, multicentre, randomised controlled trial
The Lancet Primary Care 2025cited by 9position: contributordoi
Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: A population-based cohort study
Journal of Infection 2025cited by 7position: contributordoi
Adaptation of the WHO AWaRe (Access, Watch, Reserve) antibiotic classification to support national antimicrobial stewardship priorities in the UK: findings from a modified Delphi approach to achieve expert consensus.
2025cited by 6position: contributordoi
A rapid literature review of the impact of penicillin allergy on antibiotic resistance.
2025cited by 2position: contributordoi
Penicillin allergy de-labelling implementation intervention in a UK hospital: a process evaluation, the patient experience.
2025cited by 1position: contributordoi
ElastoMeric Infusion Pumps for Hospital AntibioTICs (EMPHATIC): A Feasibility Study.
2025cited by 0position: contributordoi
The cost-effectiveness of penicillin allergy testing: Evidence and gaps from a systematic review.
2025cited by 0position: contributordoi
Assessing a penicillin allergy de-labelling implementation intervention in a UK hospital: a process evaluation reporting healthcare workers' experiences.
2025cited by 0position: contributordoi
The UK Antimicrobial Registry (UKAR): an overview of the first 20 months of recruitment.
2025cited by 0position: contributordoi
Healthcare professionals' experiences of de-labelling erroneous penicillin allergy records in general practice: a qualitative study.
2025cited by 0position: contributordoi
Procalcitonin evaluation of antibiotic use in COVID-19 hospitalised patients: The PEACH mixed methods study.
2025cited by 0position: contributordoi
Direct oral penicillin challenge in secondary care with low-risk patients: the SPACE mixed-methods study with cost-effectiveness analysis.
2025cited by 0position: contributordoi
Faux paw: Capnocytophaga canimorsus endocarditis following a dog lick: A case report
2025cited by 0position: contributordoi
Faux paw: Capnocytophaga canimorsus endocarditis following a dog lick: A case report
2025cited by 0position: contributordoi
Experiences of an inpatient penicillin allergy de-labelling pathway: capturing the patient voice.
2024cited by 10position: contributordoi
Non-allergist healthcare workers views on delivering a penicillin allergy de-labelling inpatient pathway: identifying the barriers and enablers.
2024cited by 7position: contributordoi
Narrative review of recent developments and the future of penicillin allergy de-labelling by non-allergists.
2024cited by 6position: contributordoi
The cost-effectiveness of procalcitonin for guiding antibiotic prescribing in individuals hospitalized with COVID-19: part of the PEACH study.
2024cited by 4position: contributordoi
Evidence of quality of life for hospitalised patients with COVID-19: a scoping review.
2024cited by 3position: contributordoi
A retrospective propensity-score-matched cohort study of the impact of procalcitonin testing on antibiotic use in hospitalized patients during the first wave of COVID-19.
2024cited by 2position: contributordoi
Eliciting the barriers and enablers towards anaesthetists giving penicillin-based antibiotic prophylaxis to low-risk patients who have had their penicillin allergy label removed as part of a preoperative delabelling process.
2024cited by 1position: contributordoi
Introducing the UK Antimicrobial Registry (UKAR) study: providing real world data on new antimicrobials to support antimicrobial stewardship and tackle antimicrobial resistance.
2024cited by 1position: contributordoi
The effectiveness of interventions that support penicillin allergy assessment and delabeling of adult and pediatric patients by nonallergy specialists: a systematic review and meta-analysis.
2023cited by 53position: contributordoi
Penicillin allergy de-labelling by non-allergists: a comparison of testing protocols.
2023cited by 6position: contributordoi
Health outcomes of penicillin allergy testing in children: a systematic review.
2023cited by 6position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 56 papers (2019–2026)Neil Powell · Elsevier, Inc.13 papers (2022–2026)Sarah Tonkin-Crine · National Institute for Health and Care Research11 papers (2023–2026)Enitan D. Carrol · University of Liverpool9 papers (2021–2024)Paul Dark · Manchester Academic Health Science Centre6 papers (2021–2024)Sue H Pavitt · University of Sheffield6 papers (2019–2026)Stuart Bond · Springer Nature6 papers (2021–2025)Joanne Euden · Cardiff University6 papers (2021–2024)Philip Howard · Leeds Teaching Hospitals NHS Trust6 papers (2023–2026)Martin J. Llewelyn · National Institute for Health Research6 papers (2021–2025)Robert West · BHP (Australia)5 papers (2022–2025) · 5 papers (2021–2024)D. A. Paterson · Institute of Physics5 papers (2019–2022)J. Cliff Jones · University of Hull5 papers (2019–2022)Shadia Ahmed · Leeds Teaching Hospitals NHS Trust5 papers (2023–2025)Helen F. Gleeson · American Chemical Society5 papers (2019–2022)Peng Bao · Nanjing University5 papers (2019–2022)Tamas Szakmany · Bradford Royal Infirmary5 papers (2021–2024)Mathew Upton · University of Plymouth5 papers (2023–2025)Philip Pallmann · Cardiff Metropolitan University4 papers (2021–2024)